The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I/II clinical trials of dendritic cell-based immunotherapy in patients with the biochemical relapse of the prostate cancer.
Radek Spisek
No relevant relationships to disclose
Michal Podrazil
No relevant relationships to disclose
Marek Babjuk
No relevant relationships to disclose
Ladislav Jarolim
No relevant relationships to disclose
Jitka Fucikova
No relevant relationships to disclose
Anna Fialova
No relevant relationships to disclose
Ivo Minarik
No relevant relationships to disclose
Hana Hromadkova
No relevant relationships to disclose
Jirina Bartunkova
No relevant relationships to disclose